Assessing Value- & Cost-effectiveness: How to Compare Novel Cell and Gene Therapies with Current Standards of Care to Improve Decision-Making
Time: 9:30 am
day: Conference Day Two
Details:
- Developing a value framework to justify the benefits behind the pricing.
- Analyzing cost-effectiveness, i.e., balancing the therapy's cost relative to its benefits and outcomes achieved, considering factors like quality-adjusted life years gained
- How does each particular C&G treatment impact the overall treatment paradigm and economy?
